Healthcare -
Medical - Devices - NASDAQ - US
$ 9.03
-0.769 %
$ 238 M
Market Cap
-3.78
P/E
Price Target
Average
27.35%
Revenue Forecast
Estimate
88.65%
EBIT
Estimate
--97.62%
Net Income
Estimate
93.08%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
AVITA Medical, Inc.
Wall Street analysts predict an average 1-year price target for RCEL of $11.5 , with forecasts ranging from
a
low of
$9 to a high of $14 .
RCEL Lowest Price Target
Wall Street Target
9 USD
-0.33%
RCEL Average Price Target
Wall Street Target
11.5 USD
27.35%
RCEL Highest Price Target
Wall Street Target
14 USD
55.04%
REVENUE FORECAST
Revenue Forecast Chart RCEL
EBIT FORECAST
EBIT Forecast Chart RCEL
NET INCOME FORECAST
Net Income Chart RCEL